As each thyroid cancer has distinct clinical characteristics, it is necessary to increase the sample size and analyze the relationship between clinical–pathological variables and PD-L1 expression for each thyroid cancer subtype. This evidence concerns the gene CD274 and thyroid gland carcinoma.